Top Markets
Coin of the day
Ibere Pharmaceuticals Ibere Pharmaceuticals

Ibere Pharmaceuticals

IBER
Rank in Stocks #19087
Ibere Pharmaceuticals currently lacks significant operational activities, with... Ibere Pharmaceuticals currently lacks significant operational activities, with its core mission focused on executing a business combination. This could involve a merger, an acquisition of assets or shares, or a corporate restructuring with one or more other entities. The company was founded in 2020 and is based in Philadelphia, Pennsylvania.
Share Price
$10.18
Last synced: 2023-03-01
Market Cap
$175.61M
Change (1 day)
-0.29%
Change (1 year)
0.00%
Country
US
Trade Ibere Pharmaceuticals (IBER)
Operating Margin for Ibere Pharmaceuticals (IBER)
Operating Margin as of 2026 TTM: 0.00%
According to Ibere Pharmaceuticals latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Ibere Pharmaceuticals from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
0.00% -
US
0.00% -
US
0.00% -
CN
0.00% -
US
0.00% -
US
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.